Literature DB >> 19339192

An improved synthesis of 4-[18F]-ADAM, a potent serotonin transporter imaging agent.

Ya-Yao Huang1, Wen-Sheng Huang, Tieh-Chi Chu, Chyng-Yann Shiue.   

Abstract

An improved synthesis of N,N-dimethyl-2-(2-amino-4-[(18)F]fluorophenylthio)benzylamine (4-[(18)F]-ADAM, 2) as a potent serotonin transporter (SERT) imaging agent is described. Molecular orbital (MO) calculation predicts that N,N-dimethyl-2-(2-nitro-4-trimethylammoniumtrifluoromethanesulfonylphenylthio)benzamide (8) is probably a better precursor than N,N-dimethyl-2-(2,4-dinitrophenylthio)benzylamine (1) for preparing 2. Radioligand 2 was synthesized by the reaction of either precursor 1 or precursor 8 with K[(18)F]/K(2.2.2) at 120 degrees C followed by reduction with BH(3) at 80 degrees C. The radiochemical yield (EOB) of 2 synthesized from precursor 1 and 8 was 5.7+/-2.4% (n=6) and 14.8+/-4.0% (n=5), respectively, in a synthesis time of 120 min from EOB. The specific activity of 2 was 3 Ci/micromol or 111 GBq/micromol (EOB). Thus, this new synthetic method has significantly improved the radiochemical yield of 4-[(18)F]-ADAM and makes this radioligand more accessible to PET Centers without a cyclotron.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339192     DOI: 10.1016/j.apradiso.2009.02.090

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  8 in total

1.  In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.

Authors:  Julie L Wang; Shunichi Oya; Ajit K Parhi; Brian P Lieberman; Karl Ploessl; Catherine Hou; Hank F Kung
Journal:  Nucl Med Biol       Date:  2010-05       Impact factor: 2.408

2.  PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.

Authors:  Wen-Sheng Huang; San-Yuan Huang; Pei-Shen Ho; Kuo-Hsing Ma; Ya-Yao Huang; Chin-Bin Yeh; Ren-Syuan Liu; Cheng-Yi Cheng; Chyng-Yann Shiue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-05       Impact factor: 9.236

3.  Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[18F]-ADAM PET/MRI.

Authors:  Skye Hsin-Hsien Yeh; Yu-Yeh Kuo; Wen-Sheng Huang; Chuang-Hsin Chiu; Tsung-Hsun Yu; Leo Garcia Flores Ii; Chi-Jung Tsai; Cheng-Yi Cheng; Kuo-Hsing Ma
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

Review 4.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

5.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

6.  Toxicity and radiation dosimetry studies of the serotonin transporter radioligand [(18) F]AFM in rats and monkeys.

Authors:  Ya-Yao Huang; Chen-Yi Cheng; Wen-Sheng Huang; Kuo-Hsing Ma; Ta-Wei Tseng; Ta-Kai Chou; Yiyun Huang; Chyng-Yann Shiue
Journal:  EJNMMI Res       Date:  2014-12-29       Impact factor: 3.138

7.  In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine.

Authors:  Wen-Sheng Huang; Guann-Juh Chen; Tung-Han Tsai; Chen-Yi Cheng; Chyng-Yann Shiue; Kuo-Hsing Ma; Skye Hsin-Hsien Yeh
Journal:  EJNMMI Res       Date:  2019-09-18       Impact factor: 3.138

8.  Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging.

Authors:  Chi-Jung Tsai; Chuang-Hsin Chiu; Yu-Yeh Kuo; Wen-Sheng Huang; Tsung-Hsun Yu; Leo Garcia Flores; Skye Hsin-Hsien Yeh; Kuo-Hsing Ma
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.